Skip to main content
Premium Trial:

Request an Annual Quote

Metabolon Collaborates with Euro Sample Banks on Pre-Diabetes Dx

NEW YORK (GenomeWeb News) – Metabolon will collaborate with a group of European research centers to find biomarkers that are related to insulin resistance in an effort to develop a test that could detect diabetes before an individual has the disease.
Under the collaboration, Metabolon said it will discover and validate biomarkers from samples collected from studies conducted at 19 different clinical research centers that are members of the European Group for the Study of Insulin Resistance.
Insulin resistance generally is an asymptomatic condition that can precede the arrival of type 2 diabetes, and it is estimated to affect around one-third of the adult population in the US, or around 75 million people, the company said. 
The company plans to use the research to speed up development of its Quantose test for screening of pre-diabetic patients.
Metabolon CEO John Ryals said the “routine test will help identify pre-diabetic patients years before they become diabetic,” and that it could be used to help doctors “intervene with lifestyle or drug therapies which may delay or prevent the onset of type 2 diabetes.”
Financial terms of the collaboration were not released.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.